Value through Innovation

main navigation

jump to content to meta navigation
Headillu

page content

jump to main navigation to meta navigation

Boehringer Ingelheim Press Releases

See the latest Boehringer Ingelheim news releases. To quickly find all news releases on a specific topic, please use the fulltext search.

Press Release Archive

back 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
31.08.2010 Combination therapy of telmisartan and amlodipine provides significantly better blood pressure lowering than either agent alone - For non-US and non-UK Healthcare Media only
30.08.2010 A new era for patients with atrial fibrillation - Dabigatran etexilate at the forefront - For non-US Heathcare Media and Medical Media only
29.08.2010 New Global Campaign Aims to Prevent As Many As 1 Million Atrial Fibrillation-Related Strokes - For non-US and non-UK Healthcare Media only
29.08.2010 Sub-Analysis Shows Primary Benefits seen with RE-LY® are Independent of Level of Centre-Based International Normalized Ratio Control - For non-US and non-UK Medical Media only
27.08.2010 Boehringer Ingelheim celebrates its 125-year
existence and looks to the future with confidence
26.08.2010 Boehringer Ingelheim inaugurates the Shanghai “Center of Competence” as a part of the company’s EUR 100 million expansion project in China
10.08.2010 Boehringer Ingelheim successfully concluded the purchase of Fort Dodge cattle vaccines for its Mexican business
05.08.2010 Turnover and profit expectations fulfilled for first half-year results / New growth expected from innovative medicines
26.07.2010 European Committee for Medicinal Products for Human Use (CHMP) adopts Positive Opinion for TWYNSTA®, Boehringer Ingelheim’s new single pill combination hypertension treatment - For non-US and non-UK Healthcare Media
22.07.2010 VERxVE study demonstrates efficacy and safety of 400mg once daily nevirapine (Viramune®) extended release (NVP XR) formulation
08.07.2010 First PCV-2 / Mycoplasma hyopneumoniae vaccine combination registered in the European Union
06.07.2010 Fekrije Selimi wins Boehringer Ingelheim’s FENS Award 2010 for Exceptional Research in Neuroscience
06.07.2010 Metacam® for pigs now also available as oral suspension
28.06.2010 Boehringer Ingelheim launches PCV2 vaccine in Russia
26.06.2010 Boehringer Ingelheim announces results of phase III data showing that linagliptin significantly lowered blood glucose with an excellent safety and tolerability profile - For non-US healthcare media only
18.06.2010 Boehringer Ingelheim Comments on June 18th FDA Advisory Committee Meeting - For NON-US and NON-UK Media Only
18.06.2010 Boehringer Ingelheim receives European approval for two new strengths for the once daily tablet formulation of Mirapexin®/Sifrol® prolonged-release for the treatment of Parkinson’ s disease - For non-US Healthcare Media
14.06.2010 Boehringer Ingelheim affirms safety of telmisartan with an analysis of 50,000 patients and strongly disagrees with the publication of Sipahi et al in Lancet Oncology June 2010 - For Medical Media Only
back 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
back to top

Contact

Boehringer Ingelheim GmbH

Corporate Headquarters
Binger Str. 173
55216 Ingelheim
Germany


Phone +49 / 6132 / 77 0
Fax +49 / 6132 / 72 0

media contacts

RSS feeds allow you to receive latest news and information about Boehringer Ingelheim.

subscribe to RSS Feed